Biblio

Grimm DR, Beswick DM, Maoz SL, Wang EW, Choby GW, Kuan EC, Chan EP, Adappa ND, Geltzeiler M, Getz AE et al..  2024.  SNOT-22 subdomain outcomes following treatment for sinonasal malignancy: A prospective, multicenter study.. Int Forum Allergy Rhinol.

Maoz SL, Wang EW, Hwang PH, Choby G, Kuan EC, Fleseriu CM, Chan EP, Adappa ND, Geltzeiler M, Getz AE et al..  2023.  Long-term quality of life after treatment in sinonasal malignancy: A prospective, multicenter study.. Int Forum Allergy Rhinol.

Fleseriu CM, Beswick DM, Maoz SL, Hwang PH, Choby G, Kuan EC, Chan EP, Adappa ND, Geltzeiler M, Getz AE et al..  2023.  Predictive factors for decreased baseline quality of life in patients with sinonasal malignancies.. Int Forum Allergy Rhinol.

Pandrangi VC, Mace JC, Abiri A, Adappa ND, Beswick DM, Chang EH, Eide JG, Fung N, Hong M, Johnson BJ et al..  2023.  Recurrence patterns among patients with sinonasal mucosal melanoma: A multi-institutional study.. Int Forum Allergy Rhinol.

Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, Poetker DM, Soler Z, Welch KC, Wise SK et al..  2021.  International consensus statement on allergy and rhinology: rhinosinusitis 2021.. Int Forum Allergy Rhinol. 11(3):213-739.

Beswick DM, Hwang PH, Adappa ND, Le CH, DO IMHumphrey, Getz AE, Suh JD, Aasen DM, Abuzeid WM, Chang EH et al..  2021.  Surgical approach is associated with complication rate in sinonasal malignancy: A multicenter study.. Int Forum Allergy Rhinol. 11(12):1617-1625.